This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07678/identifier/pdb/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07678/identifier/pubchem-compound/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07678/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07678/identifier/drugbank/

Statements

Subject Item
n2:DB07678
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB07678 n11:DB07678
dcterms:title
(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
adms:identifier
n6:DB07678 n10:99444149 n12:DRQ n13:46937088
n3:IUPAC-Name
n4:271B5BE6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5BEC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5BEB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5BE8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5BE9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5BEA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5BE4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5BE5-363D-11E5-9242-09173F13E4C5 n4:271B5BE2-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5BE3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5BF2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5BF3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5BED-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5BEE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5BF0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5BEF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5BF1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5BF8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5BFA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5BFB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5BF7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5BF6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5BF9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5BE7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5BF4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5BF5-363D-11E5-9242-09173F13E4C5